1-3 of 3
Brigitte Royer-Pokora
Close
Sort by
Journal Articles

Possible Biomarkers To Predict Response In Patients With Myelodysplastic Syndromes (MDS) Or Acute Myeloid Leukemia (AML) Treated With 5-Azacitidine

Andrea Kuendgen, MD, Catharina Müller-Thomas, MD, Petra Urbaniak, Michael Lauseker, Torsten Haferlach, MD, Tamara Alpermann, Andreia Albuquerque, PhD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Barbara Hildebrandt, PhD, Brigitte Royer-Pokora, PhD, Norbert Gattermann, MD, Rainer Haas, MD, Ulrich Germing, MD, Katharina Götze, MD
Journal: Blood
Blood (2013) 122 (21): 2757.
https://doi.org/10.1182/blood.V122.21.2757.2757
Published: 2013
Journal Articles

Prognostic Impact Of Molecular Mutations In 182 Patients With Myelodysplastic Syndromes

Andrea Kuendgen, MD, Jenny Seidler, Michael Lauseker, Torsten Haferlach, MD, Susanne Schnittger, PhD, Alexander Kohlmann, PhD, Barbara Hildebrandt, PhD, Catharina Müller-Thomas, MD, Beate Betz, PhD, Rainer Haas, MD, Norbert Gattermann, MD, Brigitte Royer-Pokora, PhD, Katharina Götze, M.D., Ulrich Germing, MD
Journal: Blood
Blood (2013) 122 (21): 2758.
https://doi.org/10.1182/blood.V122.21.2758.2758
Published: 2013
Journal Articles

Gene Expression Profiling of Philadelphia Chromosome(Ph) Negative CD34+ Hematopoietic Stem and Progenitor Cells of Patients with Ph Positive CML in Complete Molecular Remission during Therapy with Imatinib.

Frank Neumann, Nathalie Teutsch, Slawomir Kliszewski, Simone Bork, Benedikt Brors, Nadine Schimkus, Nicole Roes, Ulrich Steidl, Ulrich Germing, PD, Barbara Hildebrandt, Brigitte Royer-Pokora, Roland Eils, Norbert Gattermann, Rainer Haas, Ralf Kronenwett, PD
Journal: Blood
Blood (2004) 104 (11): 2955.
https://doi.org/10.1182/blood.V104.11.2955.2955
Published: 2004